chr11-57597584-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4
The ENST00000619430(SERPING1):c.-161A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
ENST00000619430 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152014Hom.: 0 Cov.: 30
GnomAD4 exome Cov.: 0
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152014Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74248
ClinVar
Submissions by phenotype
Hereditary angioedema type 1 Pathogenic:1
The c.-161A>G variant in SERPING1 was observed in Azerbaijanian autosomal recessive HAE family with 2 homozygous siblings. The same variant has previously been reported in Turkish autosomal recessive HAE family with 3 homozygous siblings (Büyüköztürk et all, 2009). The c.-161A>G variant was absent in 136 ethnically matched control chromosomes analyzed and was present at extremely low frequency in gnomAD v4.1.0 database (0.0002 in South Asian only). Affected members displayed a concordant complement profile with HAE-I, whereas heterozygous individuals had mild decrease of C1Inh activities within normal range. Additionally, in vitro functional studies indicate that C1INH mRNA levels in homozygous and heterozygous carriers are reduced (Büyüköztürk et all, 2009). According to our observation and the published information of Büyüköztürk et all, 2009, the c.-161A>G variant meets ACMG /ClinGen SVI guidance criteria to be classified as pathogenic: PS3, PP1_Str, PS4_Mod, PM2_Sup -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at